| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851100 | American Journal of Kidney Diseases | 2009 | 10 Pages |
Abstract
Despite considerable uncertainty about the benefits and risks in this population, for individuals with well-established traditional indications for these medications, refraining from prescribing them may be imprudent at this time. However, RCTs, as well as well-designed observational studies that adjust for nonrandom treatment assignment and longitudinal drug exposure, are needed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
James B. MD, Theresa I. PhD, RPh,